Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, 310016, China.
College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Nat Commun. 2024 Mar 15;15(1):2270. doi: 10.1038/s41467-024-46210-1.
The success of macrophage-based adoptive cell therapy is largely constrained by poor polarization from alternatively activated (M2-like) to classically activated (M1-like) phenotype in the immunosuppressive tumor microenvironment (TME). Here, we show that the engineered macrophage (eMac) with a heat-inducible genetic switch can induce both self-polarization of adoptively transferred eMac and re-polarization of tumour-associated macrophages in response to mild temperature elevation in a mouse model. The locoregional production of proinflammatory cytokines by eMac in the TME dose not only induces the strong polarization of macrophages into a classically activated phenotype, but also ensures that the side effects typical for systemically administrate proinflammatory cytokines are avoided. We also present a wearable warming device which is adaptable for human patients and can be remotely controlled by a smartphone. In summary, our work represents a safe and efficient adoptive transfer immunotherapy method with potential for human translation.
巨噬细胞过继细胞疗法的成功在很大程度上受到肿瘤免疫抑制微环境(TME)中从替代性激活(M2 样)向经典激活(M1 样)表型极化不良的限制。在这里,我们展示了具有热诱导遗传开关的工程化巨噬细胞(eMac)可以在小鼠模型中响应轻度温度升高,诱导过继转移的 eMac 的自我极化和肿瘤相关巨噬细胞的重新极化。TME 中 eMac 的局部促炎细胞因子的产生不仅诱导巨噬细胞强烈极化为经典激活表型,而且还确保避免了全身给予促炎细胞因子的典型副作用。我们还提出了一种可穿戴式加热装置,该装置适用于人类患者,并且可以通过智能手机远程控制。总之,我们的工作代表了一种安全有效的过继转移免疫治疗方法,具有潜在的人类转化前景。